BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24965234)

  • 1. Nonalcoholic fatty liver disease after pancreatoduodenectomy is closely associated with postoperative pancreatic exocrine insufficiency.
    Nakagawa N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Sasaki H; Okano K; Sueda T
    J Surg Oncol; 2014 Nov; 110(6):720-6. PubMed ID: 24965234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remnant pancreatic parenchymal volume predicts postoperative pancreatic exocrine insufficiency after pancreatectomy.
    Okano K; Murakami Y; Nakagawa N; Uemura K; Sudo T; Hashimoto Y; Kondo N; Takahashi S; Sueda T
    Surgery; 2016 Mar; 159(3):885-92. PubMed ID: 26603844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of risk factors for pancreatic exocrine insufficiency after pancreaticoduodenectomy using a 13C-labeled mixed triglyceride breath test.
    Hirono S; Murakami Y; Tani M; Kawai M; Okada K; Uemura K; Sudo T; Hashimoto Y; Nakagawa N; Kondo N; Yamaue H
    World J Surg; 2015 Feb; 39(2):516-25. PubMed ID: 25318451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced pancreatic parenchymal thickness indicates exocrine pancreatic insufficiency after pancreatoduodenectomy.
    Nakamura H; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T
    J Surg Res; 2011 Dec; 171(2):473-8. PubMed ID: 20605585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for exocrine pancreatic insufficiency after pancreatoduodenectomy with pancreaticogastrostomy.
    Nakamura H; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T
    J Gastrointest Surg; 2009 Jul; 13(7):1321-7. PubMed ID: 19415402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological loss of pancreatic exocrine cells correlates with pancreatic exocrine function after pancreatic surgery.
    Yuasa Y; Murakami Y; Nakamura H; Uemura K; Ohge H; Sudo T; Hashimoto Y; Nakashima A; Hiyama E; Sueda T
    Pancreas; 2012 Aug; 41(6):928-33. PubMed ID: 22781909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative Computed Tomography Assessments of the Pancreas Predict Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy.
    Ohgi K; Okamura Y; Yamamoto Y; Ashida R; Ito T; Sugiura T; Aramaki T; Uesaka K
    Medicine (Baltimore); 2016 Feb; 95(6):e2535. PubMed ID: 26871772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial.
    Satoi S; Sho M; Yanagimoto H; Yamamoto T; Akahori T; Kinoshita S; Nagai M; Hirooka S; Yamaki S; Nishiwada S; Ryota H; Ikeda N; Nakajima Y; Kon M
    J Hepatobiliary Pancreat Sci; 2016 Mar; 23(3):167-73. PubMed ID: 26748629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Nagai M; Sho M; Satoi S; Toyokawa H; Akahori T; Yanagimoto H; Yamamoto T; Hirooka S; Yamaki S; Kinoshita S; Nishiwada S; Ikeda N; Kwon AH; Nakajima Y
    J Hepatobiliary Pancreat Sci; 2014 Mar; 21(3):186-92. PubMed ID: 23798362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Yamazaki S; Takayama T; Higaki T; Moriguchi M; Yoshida N; Miyazaki T; Teshima Y
    J Gastroenterol; 2016 Jan; 51(1):55-62. PubMed ID: 25904096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of a 13C-labeled mixed triglyceride breath test for assessing pancreatic exocrine function after pancreatic surgery.
    Nakamura H; Morifuji M; Murakami Y; Uemura K; Ohge H; Hayashidani Y; Sudo T; Sueda T
    Surgery; 2009 Feb; 145(2):168-75. PubMed ID: 19167971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of postoperative adjuvant chemotherapy on the development of nonalcoholic fatty liver disease after pancreatoduodenectomy.
    Nishikawa M; Aosasa S; Moriya T; Noro T; Hase K; Yamamoto J
    J Surg Res; 2016 Sep; 205(1):127-35. PubMed ID: 27621009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that predict the occurrence of and recovery from non-alcoholic fatty liver disease after pancreatoduodenectomy.
    Sato T; Matsuo Y; Shiga K; Morimoto M; Miyai H; Takeyama H
    Surgery; 2016 Aug; 160(2):318-30. PubMed ID: 27211602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Sato R; Kishiwada M; Kuriyama N; Azumi Y; Mizuno S; Usui M; Sakurai H; Tabata M; Yamada T; Isaji S
    J Hepatobiliary Pancreat Sci; 2014 Aug; 21(8):562-72. PubMed ID: 24824077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system.
    Kato H; Isaji S; Azumi Y; Kishiwada M; Hamada T; Mizuno S; Usui M; Sakurai H; Tabata M
    J Hepatobiliary Pancreat Sci; 2010 May; 17(3):296-304. PubMed ID: 19809782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New onset non-alcoholic fatty liver disease after resection of pancreatic neuroendocrine tumors.
    Mackay TM; Genç CG; Takkenberg RB; Besselink MG; Somers I; Nieveen van Dijkum EJM
    J Surg Oncol; 2018 Jun; 117(7):1548-1555. PubMed ID: 29572825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of predictive factors in patients with nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Ito Y; Kenmochi T; Shibutani S; Egawa T; Hayashi S; Nagashima A; Kitagawa Y
    Am Surg; 2014 May; 80(5):500-4. PubMed ID: 24887731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia is closely associated with pancreatic exocrine insufficiency in patients with pancreatic disease.
    Shintakuya R; Uemura K; Murakami Y; Kondo N; Nakagawa N; Urabe K; Okano K; Awai K; Higaki T; Sueda T
    Pancreatology; 2017; 17(1):70-75. PubMed ID: 27743711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional remnant pancreatic volume ratio indicates postoperative pancreatic exocrine insufficiency in pancreatic cancer patients after distal pancreatectomy.
    Miyamoto R; Inagaki Y; Ikeda N; Oda T
    Pancreatology; 2020 Jul; 20(5):867-874. PubMed ID: 32654989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of pancreatic exocrine insufficiency after pancreatic surgery measured by
    Hartman V; Roeyen E; Bracke B; Huysentruyt F; De Gendt S; Chapelle T; Ysebaert D; Hendrikx B; Roeyen G
    Pancreatology; 2023 Aug; 23(5):563-568. PubMed ID: 37301695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.